Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lantheus makes pharma veteran Jeffrey Bailey CEO

This article was originally published in Clinica

Executive Summary

Imaging agent specialist Lantheus Medical Imaging has appointed Jeffrey Bailey as its president and CEO, succeeding Donald Kiepert, who has resigned "to pursue other opportunities" after leading the firm for five years. Mr Bailey was previously chief operating officer of Fougera Pharmaceuticals, a position he held since 2011. Before this, he was COO of King Pharmaceuticals (from August 2010 until August 2011); general manager at Novartis (2008-2010); and national sales director for Johnson & Johnson (1984-2006) and its Janssen Pharmaceutica division (2004-2006). Lantheus has also named a new chairman, Brian Markison, who has been a board member since September.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel